This inventor holds 1 USPTO granted patent. Top assignees: Novozymes A/s, Novozymes, Inc.. Active years: 2015.
Company Filing History:
1 out of 1,417 
1 out of 384 
Years Active: 2015
Title: Innovations in Lipase Variants by Deborah Yaver
Introduction
Deborah Yaver is an accomplished inventor based in Davis, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on lipase variants. Her research focuses on enhancing the efficacy of lipases for various medical applications.
Latest Patents
Deborah Yaver holds a patent for "Lipase variants for pharmaceutical use." This invention relates to lipases that comprise amino acids 1-269 of SEQ ID NO: 2, which can be used in combination with a protease and/or an amylase. The medical indications for her invention include the treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, and both type I and type II diabetes. The lipases developed in her research demonstrate improved digestion performance in vitro, enhanced activity at neutral pH, and increased stability against protease degradation, pepsin, and bile salts.
Career Highlights
Throughout her career, Deborah has worked with notable companies such as Novozymes A/S and Novozymes, Inc. Her experience in these organizations has contributed to her expertise in enzyme technology and pharmaceutical applications.
Collaborations
Deborah has collaborated with esteemed colleagues, including Michael Skjoet and Peter Colin Gregory. These partnerships have further enriched her research and development efforts in the field of lipase variants.
Conclusion
Deborah Yaver's innovative work on lipase variants showcases her dedication to advancing pharmaceutical applications. Her contributions have the potential to significantly impact the treatment of various digestive disorders and metabolic conditions.